…ough in phase 3 trials of gefapixant (COUGH-1/-2 [ NCT03449134, NCT03449147]) included the Leicester Cough Questionnaire (LCQ) and cough se…
All extracted funders
Showing 601–660 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Articles mentioning funders
5,089 articles · page 121 of 425…h PROs vs PGIC in two phase 3 trials (COUGH-1/-2 [ NCT03449134, NCT03449147]).Methods COUGH-1/-2 methods have previously been reported (McG…
…owledgements This project was supported by a project grant from Chiesi Limited.Reference Murphy AC, et al. BMJ Open Respir Res. 2024;11:e00257…
…bial resistance (AMR) is an escalating global health threat and WHO priority. Patients with chronic respiratory disease are vulnera…
…ortunities to improve care.Methods Centres were invited via the NTM Network UK to complete an online retrospective survey. At each site, anony…
…odel of care effectively aligns with the future requirements of NHS England to provide high-quality care for ILD closer to home.…
…l. Lancet. 2024;403(10423):271–81.Global Initiative for Asthma (GINA). 2025 GINA strategy report. https://ginasthma.org/2025-gina-st…
…bilitation Services Accreditation Scheme (PRSAS), hosted by the Royal College of Physicians (RCP), was launched in April 2018 to improve the quality of UK …
…ation of clinical services, to measure PR services in line with British Thoracic Society national guidance. The aim of this study is to determine the im…
…ates duplication, and supports personalised care, aligning with NHS priorities.Results demonstrate marked improvements in confidenc…
…ent that need to be acknowledged and addressed if the 2024 BTS, NICE, SIGN asthma guideline recommendations are to be fully implemen…
…Introduction and Objectives NICE and GINA guidelines recognise that ethnicity can impact asthma …